Consensus EPS · Q2 2026
$1.95
Consensus revenue · Q2 2026
$22.4B
Analysts
4
Expected report
Jul 29, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 4 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $20.6B | $22.4B | $24B |
| EPS | $1.87 | $1.95 | $2.05 |
| EBITDA | $1.1B | $1.1B | $1.1B |
| EBIT | $922.9M | $943.3M | $963.8M |
| Net income | $371.8M | $381.3M | $390.9M |
- Revenue$22.4B
- EPS$1.95
- EBITDA$1.1B
- EBIT$943.3M
- Net income$381.3M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $21.9B | $23.4B | -6.5% | $1.83 | $0.88 | +107.3% |
- Q1 2026-6.5%+107.3%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Bunge Global S.A. (BG) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 0 analysts.
- Low
- $130.00
- Consensus
- $137.00
- Median
- $130.00
- High
- $150.00
- Current
- $123.88
- Upside
- +10.6%
Upside calculated vs most recent trading price of $123.88.
Analyst ratings
Consensus: Buy — based on 25 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 30, 2026 | Barclays | maintain | Overweight | Overweight |
| Apr 1, 2026 | Barclays | maintain | Overweight | Overweight |
| Mar 24, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Mar 11, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Mar 11, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Feb 5, 2026 | UBS | maintain | Buy | Buy |
| Feb 5, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Feb 5, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Feb 5, 2026 | Barclays | maintain | Overweight | Overweight |
| Jan 21, 2026 | JP Morgan | maintain | Overweight | Overweight |
- Apr 30, 2026BarclaysOverweight
- Apr 1, 2026BarclaysOverweight
- Mar 24, 2026JP MorganOverweight
- Mar 11, 2026Morgan StanleyOverweight
- Mar 11, 2026BMO CapitalOutperform
- Feb 5, 2026UBSBuy
- Feb 5, 2026Morgan StanleyOverweight
- Feb 5, 2026JP MorganOverweight
- Feb 5, 2026BarclaysOverweight
- Jan 21, 2026JP MorganOverweight
Frequently asked questions
Bunge Global S.A. (BG) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.